Free Trial

Dimensional Fund Advisors LP Boosts Stock Position in Healthpeak Properties, Inc. $DOC

Healthpeak Properties logo with Finance background

Key Points

  • Dimensional Fund Advisors LP has increased its stake in Healthpeak Properties, Inc. to approximately 10.4 million shares, representing a 0.7% growth and a value of around $210 million.
  • Healthpeak Properties reported earnings per share of $0.46 for the last quarter, matching analysts' expectations, along with a revenue of $694.35 million, which was slightly below estimates.
  • The company has recently announced a dividend of $0.1017, set to be paid on August 29, reflecting a dividend payout ratio of 508.33% and a yield of 705.0%.
  • Want stock alerts on Healthpeak Properties? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Dimensional Fund Advisors LP boosted its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 0.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,392,052 shares of the real estate investment trust's stock after purchasing an additional 76,978 shares during the period. Dimensional Fund Advisors LP owned about 1.50% of Healthpeak Properties worth $210,126,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in DOC. Townsquare Capital LLC increased its stake in shares of Healthpeak Properties by 5.9% during the fourth quarter. Townsquare Capital LLC now owns 10,461 shares of the real estate investment trust's stock valued at $212,000 after buying an additional 584 shares during the period. CreativeOne Wealth LLC increased its stake in shares of Healthpeak Properties by 52.5% during the fourth quarter. CreativeOne Wealth LLC now owns 14,016 shares of the real estate investment trust's stock valued at $284,000 after buying an additional 4,826 shares during the period. NewEdge Advisors LLC increased its stake in shares of Healthpeak Properties by 10.5% during the fourth quarter. NewEdge Advisors LLC now owns 14,409 shares of the real estate investment trust's stock valued at $292,000 after buying an additional 1,371 shares during the period. Freedom Investment Management Inc. increased its stake in shares of Healthpeak Properties by 9.8% during the fourth quarter. Freedom Investment Management Inc. now owns 19,624 shares of the real estate investment trust's stock valued at $398,000 after buying an additional 1,759 shares during the period. Finally, First Trust Advisors LP boosted its position in shares of Healthpeak Properties by 231.8% during the fourth quarter. First Trust Advisors LP now owns 478,098 shares of the real estate investment trust's stock valued at $9,691,000 after purchasing an additional 333,998 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Tommy G. Thompson bought 5,777 shares of the company's stock in a transaction dated Wednesday, May 28th. The stock was purchased at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the acquisition, the director owned 144,290 shares in the company, valued at $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Scott M. Brinker bought 2,930 shares of the company's stock in a transaction dated Thursday, July 31st. The stock was bought at an average price of $17.06 per share, with a total value of $49,985.80. Following the acquisition, the chief executive officer owned 210,416 shares in the company, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders bought 14,560 shares of company stock valued at $249,898. Company insiders own 0.23% of the company's stock.

Healthpeak Properties Price Performance

DOC traded up $0.4450 on Friday, hitting $17.7250. 8,696,799 shares of the company's stock traded hands, compared to its average volume of 8,563,543. The firm has a market cap of $12.32 billion, a price-to-earnings ratio of 73.86, a P/E/G ratio of 2.20 and a beta of 1.05. The company's 50 day simple moving average is $17.62 and its 200-day simple moving average is $18.38. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a one year low of $16.63 and a one year high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. The business had revenue of $694.35 million during the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm's revenue for the quarter was down .2% compared to the same quarter last year. During the same quarter last year, the business posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently announced a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be issued a $0.1017 dividend. The ex-dividend date is Monday, August 18th. This represents a dividend yield of 705.0%. Healthpeak Properties's payout ratio is 508.33%.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on DOC. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday. Wedbush reduced their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Scotiabank cut Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and reduced their price target for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Evercore ISI dropped their target price on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Finally, Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Seven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $21.70.

Read Our Latest Report on Healthpeak Properties

Healthpeak Properties Company Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Recommended Stories

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines